Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Invigorating Spots To Go Kayaking All over The Planet - 2Kennedy approves adding two rare disorders to newborn screenings
- 3The most effective method to Recuperate After a Dental Embed Strategy: A Far reaching Guide
- 4Europe could get 42 more days of summer by the year 2100 due to climate change
- 5Make your choice for a definitive Christmas getaway destination!
- Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
- Wizz CEO: We’re going to invest $1 b. in Israeli market
- The Delight of Perusing: Book Proposals for Each Class
- The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- The Best Music Collections of the 10 years
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
- A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- Figure out How to Adjust Your Handshake to Various Societies
